Company / SG&A Expense
PANACEA LIFE SCIENCES HOLDINGS, INC. SG&A Expense History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$1.5M
FY2023
5-year range
$1.1M / $3.1M
FY2019-FY2023
Trend
+33.2%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense returned to growth in FY2023 after 3 years of decline, reaching $1M.
Based on SEC 10-K filings.
$1M in FY2023 with a 5-year CAGR of -5.3%.
Improved from $2M to $1M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -19.6%
- 5-Year CAGR
- -5.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -5.3%, indicating a declining trend.
- In FY2023, sg&a expense increased 33.2% year-over-year.
- Peak sg&a expense was recorded in FY2019.
- Lowest sg&a expense in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -3.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $1.5M | +33.2% |
| FY2022 | $1.1M | -28.0% |
| FY2021 | $1.5M | -45.9% |
| FY2020 | $2.8M | -8.5% |
| FY2019 | $3.1M | +60.2% |
| FY2018 | $1.9M | +57.0% |
| FY2017 | $1.2M | +60.6% |
| FY2016 | $759.1K | +600.3% |
| FY2015 | $108.4K | - |
As of FY2023 · SEC Form 10-K · Last checked Jun 29, 2026